In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel

A recently developed inhibitor of retrograde transport, namely Retro-2.1, proved to be a potent and broad-spectrum lead in vitro against intracellular pathogens, such as toxins, parasites, intracellular bacteria and viruses. To circumvent its low aqueous solubility, a formulation in poly(ethylene gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinck, Robin, Nguyen, Laetitia Anvi, Munier, Mathilde, Caramelle, Lucie, Karpman, Diana, Barbier, Julien, Pruvost, Alain, Cintrat, Jean-Christophe, Gillet, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735573/
https://www.ncbi.nlm.nih.gov/pubmed/36498939
http://dx.doi.org/10.3390/ijms232314611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735573/
https://www.ncbi.nlm.nih.gov/pubmed/36498939
http://dx.doi.org/10.3390/ijms232314611

Ejemplares similares